Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
about
A functional signal profiling test for identifying a subset of HER2-negative breast cancers with abnormally amplified HER2 signaling activity.Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment responseERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breastAn Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer.Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.Genomic alterations of ERBB receptors in cancer: clinical implications.Plasma PIK3CA ctDNA specific mutation detected by next generation sequencing is associated with clinical outcome in advanced breast cancer
P2860
Q37694673-F0B22091-7C2A-49C4-B968-5DEC5D1F1A32Q37722926-D1CF5B2B-0F8C-4417-AD79-28E281BB1E05Q39218140-AF3794E1-F2BB-4ADF-974C-93C5AEC9C048Q46005851-FD588810-3535-4BC9-ACB6-B6EA689197B5Q48234912-3FC47235-1777-4700-A4E0-C8FDAA3D9EABQ49678076-45643C79-4816-43C9-BED0-F4EC0412296BQ57494109-DAB95A42-DAD3-44AB-9032-AA9ED79C4E04
P2860
Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Nonamplification ERBB2 genomic ...... anti-HER2 targeted therapies.
@en
Nonamplification ERBB2 genomic ...... anti-HER2 targeted therapies.
@nl
type
label
Nonamplification ERBB2 genomic ...... anti-HER2 targeted therapies.
@en
Nonamplification ERBB2 genomic ...... anti-HER2 targeted therapies.
@nl
prefLabel
Nonamplification ERBB2 genomic ...... anti-HER2 targeted therapies.
@en
Nonamplification ERBB2 genomic ...... anti-HER2 targeted therapies.
@nl
P2093
P2860
P356
P1433
P1476
Nonamplification ERBB2 genomic ...... anti-HER2 targeted therapies.
@en
P2093
Brian Leyland-Jones
Doron Lipson
Jeffrey S Ross
Jo-Anne Vergilio
Julia A Elvin
Laurie M Gay
Philip J Stephens
Roman Yelensky
P2860
P304
P356
10.1002/CNCR.30102
P407
P577
2016-06-10T00:00:00Z